Computational Systems Biology for Decoding Synergistic Therapeutic Mechanisms in Complex Biological Systems
Keywords:
computational systems biology; therapeutic synergy; network medicine; multi-omics integration; machine learning; complex biological systems; data governanceAbstract
The identification of synergistic therapeutic mechanisms in complex biological systems increasingly depends on computational systems biology. Single-target paradigms are insufficient for diseases governed by distributed molecular networks, where combinations of interventions can produce non-additive effects that arise from compensatory pathways, feedback loops, and cross-scale interactions. This paper examines how integrative computational architectures decode these mechanisms. It discusses network-based representations of molecular interactions, multi-omics data integration, machine learning models, and simulation frameworks as complementary components of a systems-level research infrastructure. Emphasis is placed on structural trade-offs among predictive accuracy, interpretability, scalability, and biological realism. The analysis further addresses robustness, fairness, generalizability, data governance, and the translational deployment of synergy prediction models. By connecting computational methods to the organizational properties of complex biological systems, the paper argues that reliable therapeutic synergy discovery requires not only algorithmic advancement but also coherent data infrastructure, model validation standards, and policy frameworks that support transparent and equitable translation. Future directions include tighter coupling between causal inference, dynamic network modeling, and clinically representative validation cohorts, as well as sustainable governance mechanisms for reusable predictive models and multimodal biomedical data.
References
1. Kitano, H. (2002). Systems biology: A brief overview. Science, 295(5560), 1662–1664. https://doi.org/10.1126/science.1069492
2. Barabási, A.-L., & Oltvai, Z. N. (2004). Network biology: Understanding the cell's functional organization. Nature Reviews Genetics, 5(2), 101–113. https://doi.org/10.1038/nrg1272
3. Hopkins, A. L. (2008). Network pharmacology: The next paradigm in drug discovery. Nature Chemical Biology, 4(11), 682–690. https://doi.org/10.1038/nchembio.118
4. Jia, J., Zhu, F., Ma, X., Cao, Z. W., Li, Y. X., & Chen, Y. Z. (2009). Mechanisms of drug combinations: Interaction and network perspectives. Nature Reviews Drug Discovery, 8(2), 111–128. https://doi.org/10.1038/nrd2683
5. Loewe, S. (1953). The problem of synergism and antagonism of combined drugs. Arzneimittel-Forschung, 3(6), 285–290.
6. Bliss, C. I. (1939). The toxicity of poisons applied jointly. Annals of Applied Biology, 26(3), 585–615. https://doi.org/10.1111/j.1744-7348.1939.tb06990.x
7. Keith, C. T., Borisy, A. A., & Stockwell, B. R. (2005). Multicomponent therapeutics for networked systems. Nature Reviews Drug Discovery, 4(1), 71–78. https://doi.org/10.1038/nrd1609
8. Borisy, A. A., Elliott, P. J., Hurst, N. W., Lee, M. S., Lehár, J., Price, E. R., Serbedzija, G., Zimmermann, G. R., Foley, M. A., Stockwell, B. R., & Keith, C. T. (2003). Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences, 100(13), 7977–7982. https://doi.org/10.1073/pnas.1337088100
9. Fitzgerald, J. B., Schoeberl, B., Nielsen, U. B., & Sorger, P. K. (2006). Systems biology and combination therapy in the quest for clinical efficacy. Nature Chemical Biology, 2(9), 458–466. https://doi.org/10.1038/nchembio817
10. Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011). Network medicine: A network-based approach to human disease. Nature Reviews Genetics, 12(1), 56–68. https://doi.org/10.1038/nrg2918
11. Hasin, Y., Seldin, M., & Lusis, A. (2017). Multi-omics approaches to disease. Genome Biology, 18(1), 83. https://doi.org/10.1186/s13059-017-1215-1
12. Subramanian, I., Verma, S., Kumar, S., Jere, A., & Anamika, K. (2020). Multi-omics data integration, interpretation, and its application. Bioinformatics and Biology Insights, 14, 1–24. https://doi.org/10.1177/1177932219899051
13. Zitnik, M., Agrawal, M., & Leskovec, J. (2018). Modeling polypharmacy side effects with graph convolutional networks. Bioinformatics, 34(13), i457–i466. https://doi.org/10.1093/bioinformatics/bty294
14. Wang, Yinyin, et al. "HerbSyner_Finder: a network community-based model for identifying synergistic combinations from herbal medicines and complex systems." Targetome 2.2 (2026).
15. Preuer, K., Lewis, R. P. I., Hochreiter, S., Bender, A., Bulusu, K. C., & Klambauer, G. (2018). DeepSynergy: Predicting anti-cancer drug synergy with deep learning. Bioinformatics, 34(9), 1538–1546. https://doi.org/10.1093/bioinformatics/btx806
16. Camacho, D. M., Collins, K. M., Powers, R. K., Costello, J. C., & Collins, J. J. (2018). Next-generation machine learning for biological networks. Cell, 173(7), 1581–1592. https://doi.org/10.1016/j.cell.2018.05.015
17. Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., & Zhao, S. (2019). Applications of machine learning in drug discovery and development. Nature Reviews Drug Discovery, 18(6), 463–477. https://doi.org/10.1038/s41573-019-0024-5
18. Cheng, F., Kovács, I. A., & Barabási, A.-L. (2019). Network-based prediction of drug combinations. Nature Communications, 10, 1197. https://doi.org/10.1038/s41467-019-09186-x
19. Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013). Structure and dynamics of molecular networks: A novel paradigm of drug discovery. Pharmacology & Therapeutics, 138(3), 333–408. https://doi.org/10.1016/j.pharmthera.2013.01.016
20. O'Neil, J., Benita, Y., Feldman, I., Chenard, M., Roberts, B., Liu, Y., Li, J., Kral, A., Lejnine, S., Loboda, A., Arthur, W., Cristescu, R., Haines, B. B., Winter, C., Zhang, T., Bloecher, A., & Shumway, S. D. (2016). An unbiased oncology compound screen to identify novel combination strategies. Molecular Cancer Therapeutics, 15(6), 1155–1162. https://doi.org/10.1158/1535-7163.MCT-15-0843
21. Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., Bouwman, J., Brookes, A. J., Clark, T., Crosas, M., Dillo, I., Dumon, O., Edmunds, S., Evelo, C. T., Finkers, R., ... Mons, B. (2016). The FAIR Guiding Principles for scientific data management and stewardship. Scientific Data, 3, 160018. https://doi.org/10.1038/sdata.2016.18
22. D'Amour, A., Heller, K., Moldovan, D., Adlam, B., Alipanahi, B., Beutel, A., Chen, C., Deaton, J., Eisenstein, J., Hoffman, M. D., Hormozdiari, F., Houlsby, N., Hou, S., Jerfel, G., Karthikesalingam, A., Lucic, M., Ma, Y., McLean, C., Mincu, D., ... Sculley, D. (2022). Underspecification presents challenges for credibility in modern machine learning. Journal of Machine Learning Research, 23(226), 1–61.
23. Beam, A. L., & Kohane, I. S. (2018). Big data and machine learning in health care. JAMA, 319(13), 1317–1318. https://doi.org/10.1001/jama.2017.18391
24. Wiens, J., Saria, S., Sendak, M., Ghassemi, M., Liu, V. X., Doshi-Velez, F., Jung, K., Heller, K., Kale, D., Saeed, M., Ossorio, P. N., Thadaney-Israni, S., & Goldenberg, A. (2019). Do no harm: A roadmap for responsible machine learning for health care. Nature Medicine, 25(9), 1337–1340. https://doi.org/10.1038/s41591-019-0548-6
25. Kourou, K., Exarchos, T. P., Exarchos, K. P., Karamouzis, M. V., & Fotiadis, D. I. (2015). Machine learning applications in cancer prognosis and prediction. Computational and Structural Biotechnology Journal, 13, 8–17. https://doi.org/10.1016/j.csbj.2014.11.005
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Bioinformatics Insights and Analytics
This work is licensed under a Creative Commons Attribution 4.0 International License.
